Viral suppression rates in Mozambique declined by 33% among adults and 43% among children between February and May 2025 compared to the same period in 2024, due to cuts to U.S. HIV-related funding.
Date: 7/25
Region: Africa
Country: Mozambique
Topic: Health
Policy Lens: Global Health Security
Entry Type: Human Impact
Additional Context: This information was included in the International AIDS Society's 2025 Conference Report. As noted, to assess the impact of PEPFAR funding cuts on HIV service provision, the country's district health information system was used to compare absolute and relative changes in ART initiation and viral load cascade performance between February 2024 and February 2025. If reductions in HIV service activity continue at levels observed between February and May 2025, epidemic modeling projects an additional 83,000 HIV acquisitions and 14,000 HIV-related deaths in Mozambique by 2030, representing increases of 15% and 10% above trend.
Devex Researcher Note: In Mozambique, PEPFAR-supported facilities ran treatments for 82% of people living with HIV. U.S. Data between 2017 and 2022 consistently shows PEPFAR funding upwards of 66% of all HIV-related expenditures in the country. Though funding was initially frozen in early 2025, many of the "lifesaving" PEPFAR programs rebounded globally, including in Mozambique, while other non-medical but vital support services ended for good. The confusion and disruptions of the initial funding freeze have led to mistrust, misinformation, and harmful coping strategies
Source: IAS

